GENEVA, Aug. 10 -- HANGZHOU ZHONGMEIHUADONG PHARMACEUTICAL CO., LTD. (No. 866, Moganshan Road, Gongshu DistrictHangzhou, Zhejiang 310011), 杭州中美华东制药有限公司 (中国浙江省杭州市拱墅区莫干山路866号) filed a patent application (PCT/CN2025/075477) for "USE OF EGFR INHIBITOR" on Jan 27, 2025. With publication no. WO/2025/162446, the details related to the patent application was published on Aug 07, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (W...